North America Breast Imaging Market

North America Breast Imaging Market Size (2023 to 2028)

The Breast Imaging market size in North America is forecasted to grow USD 2.02 billion by the end of 2028 from USD 1.35 billion in 2023, registering a CAGR of 8.5% during the forecast period.

The growing incidence of breast cancer among women across North America is one of the key factors propelling the growth of the breast imaging market in North America. Breast cancer is one of the most prevalent cancers among women in the United States, following skin cancer. Hormonal fluctuations primarily contribute to its occurrence. Approximately 264,000 cases are reported annually in women, with an additional 2,400 cases in men. Breast cancer is commonly observed in women aged 50 years and older. Various breast imaging methods, including mammography, ultrasound, MRI, and CT scans, aid in early cancer detection and assessment. Mammography, a widely employed imaging technique, is pivotal for identifying cancer and potential malignancies in breast tissues, facilitating early intervention.

The growing awareness regarding the advantages of breast imaging contributes to breast imaging market growth in North America. Heightened literacy rates among women and implementing breast health programs in corporate settings drive the inclination towards early detection through breast imaging procedures.

The continual evolution of imaging techniques has fuelled the demand for breast imaging and the trend is likely to fuel in the coming years and propel the regional market growth. Manufacturers and researchers prioritize advanced technologies, including artificial intelligence, to enhance breast imaging devices' clarity for issue detection. Integrating 3D imaging technology and minimizing radiation exposure are key focus areas. The growing investments in research and development, increasing support from the governments of North American countries and favorable reimbursement policies further boost the growth rate of the North American market.

The high costs associated with breast imaging majorly hamper the growth of the North American breast imaging market. Factors such as expensive imaging equipment, limited skilled workforce, inadequate awareness of imaging techniques, low reimbursement policies and prolonged device approval processes impede the regional market growth. Factors such as potential radiation concerns post-procedure and the difficulty in distinguishing abnormal and normal cells inhibit the growth rate of the regional market.

This research report on the North America Breast Imaging Market has been segmented and sub-segmented into the following categories:

By Technology:

• Ionizing Technologies
  • Mammography
  • Digital Mammography
  • 3D Mammography
  • Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
  • Positron Emission Tomography and Computed Tomography (PET-CT)
  • Cone-Beam Computed Tomography (CBCT)
  • Positron Emission Mammography (PEM)
• Non-ionizing Technologies
  • Breast MRI
  • Breast Ultrasound
  • Automated Whole-Breast Ultrasound (AWBU)
  • Breast Thermography
  • Optical Imaging

By Country:

• The United States
• Canada
• Rest of North America

North America held the largest share of the global market in 2022 and the domination of the North American region is expected to continue throughout the forecast period owing to the presence of technologically well-developed healthcare infrastructure, rising healthcare expenditures, government interventions in novel imaging device approval and heightened patient care. The growing awareness campaigns by healthcare organizations about breast cancer and imaging procedures favor the growth of the North American market. The U.S. breast imaging market is expected to hold the leading share of the North American market during the forecast period owing to robust manufacturing facilities and growing clinical trial centers. The proliferation of specialized hospitals for breast cancer, free examination programs, and strong healthcare infrastructure propel the U.S. market growth. Canada is anticipated to grow at a healthy CAGR in the coming years owing to research labs and increasing mergers and acquisitions. Advancements in breast imaging training centers and healthcare infrastructure further propel the market.

Some of the key players dominating the breast imaging market in North America are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.